Integrated pharmaco-proteogenomics defines two subgroups in isocitrate dehydrogenase wild-type glioblastoma with prognostic and therapeutic opportunities

التفاصيل البيبلوغرافية
العنوان:	Integrated pharmaco-proteogenomics defines two subgroups in isocitrate dehydrogenase wild-type glioblastoma with prognostic and therapeutic opportunities
المؤلفون:	Oh, Sejin^{Aff1, Aff2}, Yeom, Jeonghun^{Aff3, Aff4, Aff5}, Cho, Hee Jin^{Aff6, Aff7}, Kim, Ju-Hwa, Yoon, Seon-Jin^{Aff2, Aff9}, Kim, Hakhyun, Sa, Jason K., Ju, Shinyeong^{Aff3, Aff11}, Lee, Hwanho^{Aff2, Aff12}, Oh, Myung Joon, Lee, Wonyeop, Kwon, Yumi^{Aff3, Aff11}, Li, Honglan^{Aff13, Aff14}, Choi, Seunghyuk, Han, Jang Hee^{Aff1, Aff15}, Chang, Jong Hee, Choi, Eunsuk^{Aff6, Aff17}, Kim, Jayeon^{Aff6, Aff7}, Her, Nam-Gu, Kim, Se Hoon, Kang, Seok-Gu^{Aff15, Aff16}, Paek, Eunok^Aff13, Nam, Do-Hyun^{Aff6, Aff17, Aff19}, Lee, Cheolju^{Aff3, Aff4, Aff20}, Kim, Hyun Seok^{Aff1, Aff2}
المصدر:	Nature Communications. 11(1)
قاعدة البيانات:	Springer Nature Journals

الوصف
تدمد:	20411723
DOI:	10.1038/s41467-020-17139-y